Chemotherapy-resistant breast cancer uses exosomal miR-222 to reprogram macrophages in TME and, by targeting PTEN, initiates the Akt signaling cascade that promotes M2 macrophage polarization. The gene discussed is PTEN; the disease is breast carcinoma.